References
Visvader JE . Cells of origin in cancer. Nature 2011; 469: 314–322.
Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E . Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 2007; 67: 8671–8681.
Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE . The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008; 68: 7711–7717.
Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q et al. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFbeta signaling. Oncogene 2012; 31: 2614–2626.
Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007; 9: 201–209.
Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009; 15: 907–913.
Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012; 148: 1015–1028.
Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993–997.
Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast cancer research: BCR 2010; 12: R21.
Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU . Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 2004; 23: 6980–6985.
Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C et al. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer cell 2010; 17: 65–76.
Booth BW, Boulanger CA, Smith GH . Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation. J Cell Physiol 2007; 212: 729–736.
Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 1992; 89: 10578–10582.
Matulka LA, Triplett AA, Wagner KU . Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev Biol 2007; 303: 29–44.
Smith GH, Medina D . Re-evaluation of mammary stem cell biology based on in vivo transplantation. Breast cancer research: BCR 2008; 10: 203.
Visvader JE, Lindeman GJ . The unmasking of novel unipotent stem cells in the mammary gland. EMBO J 2011; 30: 4858–4859.
Boulanger CA, Wagner KU, Smith GH . Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene 2005; 24: 552–560.
Visvader JE . Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009; 23: 2563–2577.
Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G . Ductal growth is impeded in mammary glands of C-neu transgenic mice. Oncogene 2000; 19: 5982–5987.
Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF . ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci USA 2004; 101: 17138–17143.
Andrechek ER, White D, Muller WJ . Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth. Oncogene 2005; 24: 932–937.
Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW . Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer cell 2006; 9: 13–22.
Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML et al. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439: 84–88.
Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011; 479: 189–193.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lo, PK., Chen, H. Cancer stem cells and cells of origin in MMTV-Her2/neu-induced mammary tumorigenesis. Oncogene 32, 1339–1340 (2013). https://doi.org/10.1038/onc.2012.456
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.456
- Springer Nature Limited
This article is cited by
-
Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential
Journal of Mammary Gland Biology and Neoplasia (2023)
-
Use of constitutive and inducible oncogene-containing iPSCs as surrogates for transgenic mice to study breast oncogenesis
Stem Cell Research & Therapy (2021)
-
Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors
Oncogene (2018)